{'fraction_non_alphanumeric': 0.02914611682215224, 'fraction_numerical': 0.014974151761839681, 'mean_word_length': 5.542079689018465, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 1, 'zh_pornsignals.json': 0}}
Use of Probiotic Bacteria and Bacteriocins as an Alternative to Antibiotics in Aquaculture

In addition to their use in human medicine, antimicrobials are also used in food animals and aquaculture, and their use can be categorized as therapeutic against bacterial infections. The use of antimicrobials in aquaculture may involve a broad environmental application that affects a wide variety of bacteria, promoting the spread of bacterial resistance genes. Probiotics and bacteriocins, antimicrobial peptides produced by some types of lactic acid bacteria (LAB), have been successfully tested in aquatic animals as alternatives to control bacterial infections. Supplementation might have beneficial impacts on the intestinal microbiota, immune response, development, and/or weight gain, without the issues associated with antibiotic use. Thus, probiotics and bacteriocins represent feasible alternatives to antibiotics. Here, we provide an update with respect to the relevance of aquaculture in the animal protein production sector, as well as the present and future challenges generated by outbreaks and antimicrobial resistance, while highlighting the potential role of probiotics and bacteriocins to address these challenges. In addition, we conducted data analysis using a simple linear regression model to determine whether a linear relationship exists between probiotic dose added to feed and three variables of interest selected, including specific growth rate, feed conversion ratio, and lysozyme activity.


Introduction
There has been a growing global demand for animal protein, with fish representing a particularly important source. However, systematic and unbalanced human exploitation has led to an 80% reduction of the wild fish populations in the oceans. In parallel, the strong expansion of fish farming and aquaculture production has created a set of new challenges far beyond those involving the growth of the sector and its food supply chains [1]. To continue to grow, the aquaculture sector must focus on resolving difficulties through the demarcation of new breeding areas, accessing highly nutritious feed, developing new technologies and technical support, addressing logistic management limitations, and, very importantly, optimizing the ability to predict, avoid, and contain infections and diseases [2].
Fish consumption has grown in recent decades. It is estimated that a 3.2% increase occurred between 1961 and 2016, a figure that surpassed the corresponding rises in terrestrial animal protein production (2.8%). The estimated annual consumption per person has also increased significantly; for example, in 1961, average global consumption was less than 9 kilograms (kg), but by 2015, it had increased to 20.2 kg, with an additional growth from 20.3-20.5 kg estimated from 2016-2017 [3]. Most of production derived from aquaculture is intended for human consumption. By 2030, aquaculture is expected to be responsible for producing about 109 million tonnes for human consumption, compared with a predicted 74 million tonnes from exploratory fishing [3], a level of growth that is supported by low taxation levels [4,5]. However, many obstacles may hamper the predicted growth of aquaculture. Of these, the failure to predict and contain infections, diseases, and antibiotic resistance is the most perturbing [6].
As a strategy to minimize production losses due to infectious bacterial outbreaks, the use of antibiotics has been widely employed in recent decades [7]. However, their use is not sustainable and other options must be examined.
The objective of this review is to provide recent information relating to the importance of aquaculture in the animal protein production sector and its global economic impacts and growth prospects, as well as its present and future challenges generated by outbreaks and antimicrobial resistance, while highlighting the potential merits of employing probiotics and bacteriocins within this industry. Beneficial microorganisms (probiotics) and bacteriocins are novel solutions that could help reduce the use of antibiotics in aquaculture.

Antibiotics and Fish Infection Control
Along with their therapeutic applications to treat and control the spread of bacterial disease in juvenile and adult fish, antibiotics could be used as tools to avoid and prevent future infections beginning from the first days of fish development, when used as growth factors in feeding formulations [7]. This is sustained by farmers' perception that the continuous presence of small doses of antibiotics in the fish growth environment helps to significantly reduce production costs. Due to the perception established between the decreased proliferation of pathogenic microorganisms with lower production losses and decreased time required to attain market weights, the abusive and unregulated use of these important therapeutic agents has expanded worldwide [7,8] This is particularly worrying since, according to data reported by the World Health Organization (WHO) [9], a significant proportion of these antibiotics are also used as essential therapeutic agents for the treatment of bacterial diseases in humans. Therefore, the uncontrolled application of these antibiotics in animal protein production presents an enormous risk to human health [10]. Antibiotics can kill beneficial microorganisms, cause disturbances in the microbiota [11], affect nutrition and immunity [12], and their use can lead to the selection of resistant bacteria and the zoonotic transmission of resistance genes to the human microbiota [13]. Due to concerns relating to the global emergence of antibiotic resistance, global authorities and several developed countries, such as Canada, Japan, the United States, and members of the European Union, have implemented strict rules on the use of antibiotics in fish breeding [14]. Restrictions were officially approved, selecting a limited and smaller group of antibiotics that can be used in fish breeding, such as erythromycin, amoxicillin, florfenicol, oxytetracycline, oxolinic acid, flumequine, and combinations of sulphonamides [15]. Notably, a number of these antibiotics are considered essential for disease control in humans [9]. Even more importantly, these restrictions may have little impact globally as the majority of fish production is located in countries that have not adopted similar laws to regulate the use of antibiotics in animals. Thus, one can have extremes whereby, for example, Chile uses approximately 900 g of antibiotics for each tonne of fish while Norway uses only 0.17 g [14,16]. Furthermore, in Brazil, one of the top 25 aquaculture producers, many producers have increased the size of their production areas without following international standards of good environmental management practices. As a result, negative environmental effects and antibiotic-contaminated fish are common [17].
Ultimately, the continued extensive use of antibiotics by some countries is not sustainable, and as the number of bacterial disease outbreaks associated with the artificial environmental conditions of aquaculture increases and restrictive antibiotic use policies are implemented at an international level, new infectious control and prevention protocols are needed [7]. These new protocols are required to control the most common cause of fish diseases, i.e., bacterial infections. These include infections caused by Aeromonas salmonicida [15], Vibrio anguillarum [18], Streptococcus agalactiae [19], Flexibacter columnaris [20], Aeromonas hydrophila [21], Aeromonas caviae [22], Pseudomonas aeruginosa [23], Enterococcus spp. [24], Francisella noatunensis [25], and Flavobacterium psychrophilum [26].
Naturally, producers of non-antibiotic antimicrobials have received great attention as an alternative to the use of antibiotics [27]. In particular, probiotic microorganisms have been increasingly investigated as a means of improving fish defenses, especially as they are considered safe and are also frequently producers of antimicrobial peptides, such as bacteriocins [7].

Probiotic Use in Aquaculture
Probiotics are defined as live microorganisms that, when administered in adequate amounts, have the ability to confer health benefits on their host [28]. However, there is no consensus as to the value of applying probiotics to aquaculture. According to Wang et al. (2019), the way these animals relate to and are influenced by the environment is different from other animals, and so strains specifically tailored for aquaculture use need to be evaluated. Verschuere et al. (2000) proposed a new concept when defining probiotics for aquacultural use. Their concept differs from the standard definition of probiotics in that it suggests that probiotics for aquaculture use must have a beneficial action on both the host microbiota and the environment where the fish is located, optimizing the effect of food, animal health, and weight gain [29]. It is also important to note that chemical and physical factors, such as water quality (level of oxygen and carbon dioxide, temperature, pH, and presence of organic matter), fish density, or physical injury during handling, can lead to physiological reactions that culminate in the development of disease [30]. Furthermore, environmental changes or stress exposure can negatively affect fish development via immunosuppression. Thus, probiotic administration may also be targeted towards providing a protective response against these external stimuli [1].
Water and other living organisms might spread microorganisms from the gut microbiota of fish and probiotics. After reaching the host's intestinal mucosa, these microorganisms perform vital functions. Several anatomical structures of aquatic animals are sites for the growth of microorganisms, such as the skin, gills, and especially the gastrointestinal tract [1,31]. Feces and intestinal mucus of fish are the main sources of microorganisms with probiotic potential. After isolation, these microorganisms are tested and can be used as a supplement in the feeding of aquatic animals [32]. The larval stage of growth is optimal with respect to probiotic use in aquaculture, and the consequences of early colonization of these microorganisms can be amplified throughout a fish's life stages [33,34].
The probiotic microorganisms used in aquaculture have included specific strains of yeasts, algae, and especially bacteria, including representatives of Bacillus sp., Lactococcus sp., Micrococcus sp., Carnobacterium sp., Enterococcus sp., Lactobacillus sp., Streptococcus, and Weissella sp. [35]. Bacteria belonging to the group of LAB are considered GRAS, i.e., generally reported as safe [36] and can produce natural compounds with antimicrobial potential and also stimulate the immune system; thus, most probiotic studies are conducted with strains of LAB [37].
The use of probiotic microorganisms in experiments with aquatic animals has achieved promising results (Table 1), and feed supplementation effectiveness can be optimized if different approaches for the use of probiotics are tested ( Figure 1) [38], including the use of mixtures of probiotics where complementary effects can be obtained. Supplementation with prebiotics, which are nondigestible food components that benefit colonization by providing nutrients and protection to probiotic and other desirable strains, or synbiotics, which are combinations of probiotics and prebiotics in the same product, can also have value [38][39][40]. Finally, postbiotics, which are the products of probiotic growth, including bacteriocins, can also have a key role [41].
The use of probiotic microorganisms in experiments with aquatic animals has achieved promising results (Table 1), and feed supplementation effectiveness can be optimized if different approaches for the use of probiotics are tested ( Figure 1) [38], including the use of mixtures of probiotics where complementary effects can be obtained. Supplementation with prebiotics, which are nondigestible food components that benefit colonization by providing nutrients and protection to probiotic and other desirable strains, or synbiotics, which are combinations of probiotics and prebiotics in the same product, can also have value [38][39][40]. Finally, postbiotics, which are the products of probiotic growth, including bacteriocins, can also have a key role [41]. The different stages before probiotic bacteria use in aquaculture. From a sample, tests to identify genus and species are performed. Then, tests with and without the use of living organisms evaluate its properties and use as a food additive in animal feed. (B) In order to optimize aquaculture production processes, different techniques have been used. Probiotic microorganisms are those that confer benefits to the host; prebiotics are nondigestible food components that benefit the colonization of certain bacteria, such as probiotics; synbiotics are the combination of probiotics and prebiotics in the same product; mixtures of probiotics are prepared from the combination of more than one probiotic microorganism to potentiate their action; and postbiotics, dead probiotics or byproducts, are commonly associated with safety [38][39][40]42].  In order to optimize aquaculture production processes, different techniques have been used. Probiotic microorganisms are those that confer benefits to the host; prebiotics are nondigestible food components that benefit the colonization of certain bacteria, such as probiotics; synbiotics are the combination of probiotics and prebiotics in the same product; mixtures of probiotics are prepared from the combination of more than one probiotic microorganism to potentiate their action; and postbiotics, dead probiotics or byproducts, are commonly associated with safety [38][39][40]42].

Mode of Action and Benefits of Probiotic
Among the studies that have demonstrated the benefits of probiotic use, different mechanisms of action have been noted, differing by species specificities and environmental conditions that the microorganism encounters [37,117]. Probiotics have been shown to be able to decrease lactose intolerance and infant diarrhea in humans, and many promising studies have shown that they can stimulate the immune system and prevent numerous diseases, including mucosal inflammation, obesity, diabetes, heart and neurological diseases, and certain types of cancer. In this current review, the focus will be placed on the prevention of pathogenic microorganisms in aquacultural settings. Beneficial strains can function by blocking pathogenic microorganisms due to competition for space on host cell surfaces ( Figure 2) [118]. Probiotic use in feed improves the health of aquatic animals and no negative effects have been observed after consumption [14]. Strains of Lactobacillus are commonly recommended for aquaculture, and dietary supplementation results in better enzyme activity, immune response, development, weight gain, and even water quality improvement [32,119]. The stimulation of digestive enzyme production, such as amylase, protease, lipase, and lysozyme, can be an important consequence of probiotic use [118]. In healthy animals, these enzymes are intrinsically associated with improved digestibility, nutritional intake, and weight gain [120]. Improving the digestibility of certain compounds may reduce blood lipid rates and even address problems arising from the intolerance to certain compounds [32].
Among the studies that have demonstrated the benefits of probiotic use, different mechanisms of action have been noted, differing by species specificities and environmental conditions that the microorganism encounters [37,117]. Probiotics have been shown to be able to decrease lactose intolerance and infant diarrhea in humans, and many promising studies have shown that they can stimulate the immune system and prevent numerous diseases, including mucosal inflammation, obesity, diabetes, heart and neurological diseases, and certain types of cancer. In this current review, the focus will be placed on the prevention of pathogenic microorganisms in aquacultural settings. Beneficial strains can function by blocking pathogenic microorganisms due to competition for space on host cell surfaces (Figure 2) [118]. Probiotic use in feed improves the health of aquatic animals and no negative effects have been observed after consumption [14]. Strains of Lactobacillus are commonly recommended for aquaculture, and dietary supplementation results in better enzyme activity, immune response, development, weight gain, and even water quality improvement [32,119]. The stimulation of digestive enzyme production, such as amylase, protease, lipase, and lysozyme, can be an important consequence of probiotic use [118]. In healthy animals, these enzymes are intrinsically associated with improved digestibility, nutritional intake, and weight gain [120]. Improving the digestibility of certain compounds may reduce blood lipid rates and even address problems arising from the intolerance to certain compounds [32]. Probiotics and bacteriocins mode of action. Probiotics beneficial effects come from several mechanisms. They secrete digestive enzymes that contribute to macronutrients breakdown, increasing absorption by the host. They can act by blocking pathogens due to competition for space and nutrients, by stimulating the immune system (without the presence of disease) and via the production of antimicrobial substances (such as lactic acid and bacteriocins). Bacteriocins mode of action may vary according to their characteristics. They can lead to death via pore formation, preventing the action of peptidoglycan transporters and, consequently, cell wall synthesis, and via damage to genetic material and protein synthesis. Probiotics, bacteriocins, and the host nutritional improvement contribute to pathogens elimination and diseases control [121,122].
The benefits of probiotics in aquaculture extend beyond animal health and can also be used to improve water quality. The accelerated fish production process creates a stressful environment favorable to pathogenic microorganisms and diseases. However, probiotic use in fish farm systems can modify the aquatic environment and, by reducing the populations of undesirable microorganisms, reduce the chances of disease development [123]. Probiotics and bacteriocins mode of action. Probiotics beneficial effects come from several mechanisms. They secrete digestive enzymes that contribute to macronutrients breakdown, increasing absorption by the host. They can act by blocking pathogens due to competition for space and nutrients, by stimulating the immune system (without the presence of disease) and via the production of antimicrobial substances (such as lactic acid and bacteriocins). Bacteriocins mode of action may vary according to their characteristics. They can lead to death via pore formation, preventing the action of peptidoglycan transporters and, consequently, cell wall synthesis, and via damage to genetic material and protein synthesis. Probiotics, bacteriocins, and the host nutritional improvement contribute to pathogens elimination and diseases control [121,122].
The benefits of probiotics in aquaculture extend beyond animal health and can also be used to improve water quality. The accelerated fish production process creates a stressful environment favorable to pathogenic microorganisms and diseases. However, probiotic use in fish farm systems can modify the aquatic environment and, by reducing the populations of undesirable microorganisms, reduce the chances of disease development [123].
In this review, we conducted data analysis using a simple linear regression model (GraphPad Prism version 9.0, GraphPad Software, San Diego, CA, USA) to determine whether a linear relationship between probiotic dose added to feed and three variables of interest selected, including specific growth rate (SGR; 38 studies), feed conversion ratio (FCR; 32 studies), and lysozyme activity (8 studies), exists. For analysis purposes, we have only taken into account the presence or absence of probiotics without considering the type of probiotic as well as whether they were used as single or multiprobiotic treatment.
Probiotic dose added to feed was transformed to log10 for graphic representation purposes. Data analysis revealed no significant correlation (p = 0.085) between probiotic dose in feed and SGR in fish (R 2 = 0.0182; Figure 3). However, we detected a significant correlation (p = 0.014; p = 0.017) between probiotic dose in feed and FCR as well as lysozyme activity (R 2 = 0.048; R 2 = 0.163, respectively; Figures 4 and 5) in fish. These results suggest adding probiotics to the diet improves the utilization efficiency of feed in fish and thus contributes to improving the economy and well-being of fish farming. This is especially true since feed is considered to be the highest cost in aquaculture facilities, particularly in intensive culture systems where feed costs represent close to 50% of the variable production cost [124].
only taken into account the presence or absence of probiotics without considering the of probiotic as well as whether they were used as single or multiprobiotic treatment.
Probiotic dose added to feed was transformed to log10 for graphic representa purposes. Data analysis revealed no significant correlation (p = 0.085) between prob dose in feed and SGR in fish (R 2 = 0.0182; Figure 3). However, we detected a signif correlation (p = 0.014; p = 0.017) between probiotic dose in feed and FCR as well as zyme activity (R 2 = 0.048; R 2 = 0.163, respectively; Figures 4 and 5) in fish. These re suggest adding probiotics to the diet improves the utilization efficiency of feed in fish thus contributes to improving the economy and well-being of fish farming. This is e cially true since feed is considered to be the highest cost in aquaculture facilities, par larly in intensive culture systems where feed costs represent close to 50% of the var production cost [124].   of probiotic as well as whether they were used as single or multiprobiotic treatmen Probiotic dose added to feed was transformed to log10 for graphic represen purposes. Data analysis revealed no significant correlation (p = 0.085) between pro dose in feed and SGR in fish (R 2 = 0.0182; Figure 3). However, we detected a sign correlation (p = 0.014; p = 0.017) between probiotic dose in feed and FCR as well as zyme activity (R 2 = 0.048; R 2 = 0.163, respectively; Figures 4 and 5) in fish. These r suggest adding probiotics to the diet improves the utilization efficiency of feed in fis thus contributes to improving the economy and well-being of fish farming. This is cially true since feed is considered to be the highest cost in aquaculture facilities, pa larly in intensive culture systems where feed costs represent close to 50% of the va production cost [124].   The circles represent the mean of experimental groups (n = 3; either control group or probio treatment group) tested in the studies considered for the regression analysis. The improvement in fish feed utilization could be a consequence of probiotic crobes contributing directly or indirectly, via induced changes in gut microbiota com sition, to metabolize undigested nutrients via microbial enzyme activity. However, an hancement of nutrient absorption surface/capacity due to a stimulatory effect of probi microbes on gut epithelium development and gut health might contribute to this outco as well. For example, short chain fatty acids (SCF) derived from probiotic metabolism fluence epithelial cell metabolism, helping with busting diverse energy-demanding ce lar processes in enterocytes, such as producing mucin and tight junction enterocyte p teins, which contribute to the integrity of the intestinal barrier [125].
For its part, our analysis revealed that SGR was not affected by adding probiotic the diet of fish. A possible explanation of this lack of significance is due to the exponen function of SGR, showing some imprecision when determining fish growth efficiency ing either long-term data or data over different life stages. Thus, SGR should be used w fish are exactly of the same age, since the growth performance of fish during different stages introduces a bias into the calculation. Because the studies included in our anal covered different life stages and trial periods, SGR may have been an unsuitable ma matical model for comparing growth performed in these heterogenous data analysis vironments [126].
Finally, the significant positive correlation between lysozyme activity and probi dose added to feed found across the studies included in the analysis supports the i that probiotics provide health benefits to fish ( Figure 5). Lysozyme is a hydrolytic gly sidase [(β-) glycoside hydrolase that exerts several important functions related to inn immunity, including the lyse of Gram-positive and Gram-negative bacterial cell m branes (acting as an antimicrobial agent) and activation of the complement system phagocytes. It is ubiquitously distributed in several tissues, mucus, lymphoid tis plasma, and other body fluids [127]. Hence, increasing lysozyme activity by adding p biotics to feed might play an important role in enhancing fish disease resistance in in sive culture systems. The improvement in fish feed utilization could be a consequence of probiotic microbes contributing directly or indirectly, via induced changes in gut microbiota composition, to metabolize undigested nutrients via microbial enzyme activity. However, an enhancement of nutrient absorption surface/capacity due to a stimulatory effect of probiotic microbes on gut epithelium development and gut health might contribute to this outcome as well. For example, short chain fatty acids (SCF) derived from probiotic metabolism influence epithelial cell metabolism, helping with busting diverse energy-demanding cellular processes in enterocytes, such as producing mucin and tight junction enterocyte proteins, which contribute to the integrity of the intestinal barrier [125].
For its part, our analysis revealed that SGR was not affected by adding probiotics to the diet of fish. A possible explanation of this lack of significance is due to the exponential function of SGR, showing some imprecision when determining fish growth efficiency using either long-term data or data over different life stages. Thus, SGR should be used when fish are exactly of the same age, since the growth performance of fish during different life stages introduces a bias into the calculation. Because the studies included in our analysis covered different life stages and trial periods, SGR may have been an unsuitable mathematical model for comparing growth performed in these heterogenous data analysis environments [126].
Finally, the significant positive correlation between lysozyme activity and probiotic dose added to feed found across the studies included in the analysis supports the idea that probiotics provide health benefits to fish ( Figure 5). Lysozyme is a hydrolytic glycosidase [(β-) glycoside hydrolase that exerts several important functions related to innate immunity, including the lyse of Gram-positive and Gram-negative bacterial cell membranes (acting as an antimicrobial agent) and activation of the complement system and phagocytes. It is ubiquitously distributed in several tissues, mucus, lymphoid tissue, plasma, and other body fluids [127]. Hence, increasing lysozyme activity by adding probiotics to feed might play an important role in enhancing fish disease resistance in intensive culture systems.

Bacteriocin Use in Aquaculture
In recent years, bacteriocins have received substantial attention as antimicrobial compounds. Although bacteriocins have been predominantly used as food preservatives, they are now receiving better attention as potential clinical antimicrobials and as possible immune-modulating agents. Hence, bacteriocin use is another important strategy to control antibiotic-resistant bacteria and improve health [121]. Bacteriocins are a heterogeneous group of small, ribosomally-synthesized antimicrobial peptides. They can have a wide variety of producers, spectrums of action (Figure 2), and biochemical properties [121,128].
Since 1925, with the discovery of colicin, research on bacteriocins has received considerable attention [129], and by 1995, more than a hundred different types of bacteriocins had been identified [130]. Bacteriocins can provide an important competitive advantage for the species that produce them [131]. Probiotics of interest can produce bacteriocins at their site of action [132].
Several classes of bacteriocins have been evaluated [133]. Many of the bacteriocins tested for food-related applications are isolated from LAB [131]. These include nisin, which is produced by L. lactis and has been widely used as a food preservative for more than fifty years [134,135]. Others, such as pediocin PA-1, produced by Pediococcus acidilactici have been extensively studied due to their activity against Listeria monocytogenes in meat and dairy products [131]. Bacteriocins have also been investigated for their pharmaceutical application [129] because they could serve as a possible alternative to antibiotics to combat pathogenic microorganisms in live organisms [121]. As production losses in aquaculture due to bacterial diseases and bacterial resistance to antibiotics have increased [7,121], bacteriocins have been applied in aquaculture production systems due to their antimicrobial proprieties (including Gram-positive/Gram-negative inhibition) ( Table 2). However, the application of probiotics and bacteriocins in fish feed supplementation requires rigorous testing to avoid any unexpected effects. Safety is essential to current research progress [136].  In vitro antimicrobial activity against tested pathogen and Gram-positive bacteria [144] Odontesthes platensis Nisin Z Lactococcus garvieae Pathogen growth inhibition [145] Fermented fish roe Bacteriocin produced by Enterococcus faecium CN-25 Listeria monocytogenes In vitro pathogen inhibition [146] Tilapia sp., Catla catla, Cyprinus carpio Bacteriocin isolated from Pediococcus acidilactici Listeria monocytogenes In vitro antimicrobial activity against tested pathogen [147] Acipenseridae, Oncorhynchus clarkii Plantaricin LPL-1 Listeria monocytogenes In vitro antimicrobial activity against tested pathogen and Gram-positive bacteria [148] Pangasius bocourti 7293 Listeria monocytogenes, Staphylococcus aureus, Aeromonas hydrophila, Escherichia coli, Pseudomonas aeruginosa, Salmonella Typhimurium

Safety
It is important that probiotics be properly developed and that new products be verified using validated scientific research. In some countries, probiotics have been approved for use based only on initial tests that generally attest to their antimicrobial and immunostimulatory activity. Furthermore, in 2017, during inspections by the US FDA (Food and Drug Administration, Silver Spring, MD, USA), more than 50% of the establishments visited in the probiotic industry had serious violations, all related to failures during the development process, including misidentification and even contamination of supplements, which compromises product efficacy and safety [136].
The transfer of resistance genes to the host microbiota is another growing concern that could result in a loss of commercial interest. In an in vitro experiment, it was observed that Lactobacillus plantarum M345 was able to transfer a resistance gene to Listeria monocytogenes [152]. In 2005, it was reported that a probiotic product that was approved by the FDA contained a strain with resistance to an important clinical antibiotic (tetracycline) and that the gene could be transmitted [136]. The presence of resistance genes in probiotics has already been described in the literature and has been studied. As one of the main advantages of using probiotics is their safety, it is necessary to pay more attention to this problem. If not controlled, it can represent a loss of consumer interest and economic losses to the sector [120].
However, it is important to emphasize that health problems resulting from the use of probiotics are very rare, both for animals and for humans. These microorganisms are already part of the host's microbiota and any problems related to the use of probiotics are generally related to host immunity and other pre-existing diseases [153]. In addition, many countries already have very strict laws that ensure that the development and sale of probiotic products takes place safely [4,154].

Conclusions and Future Perspectives
Bacterial disease outbreaks in aquaculture systems have increased in the last few decades, and policies that restrict antibiotic use have been implemented. To avoid production losses, new therapeutic fish farming technologies and new infectious control and prevention protocols are required. The benefits of specific probiotics and bacteriocins which trigger directly or enhance the immune structure of aquatic species with respect to fish health and controlling pathogenic bacteria in aquaculture are clear. Further advancements in this area have the potential to cause a paradigm shift in aquaculture, resulting in higher quality foods, improved consumer health, increased sustainability (including environmental sustainability), and increased economic value.

Data Availability Statement:
The data that support the results of this study are available from the corresponding author upon request.

Conflicts of Interest:
The authors declare no conflict of interest.